Literature DB >> 24323352

Supercharging allografts with mesenchymal stem cells in the operating room during hip revision.

Yasuhiro Homma1, Kazuo Kaneko, Philippe Hernigou.   

Abstract

PURPOSE: Bone marrow derived mesenchymal stem cells (BM-MSCs) have been proposed to improve allografts used during hip revision. However, no study has reported the number of MSCs that could be associated with the allograft and the best technique to load MSCs in allografts. The optimal loading technique should combine methods to increase the initial cell density and create an appropriate environment to accelerate the efficiency of the cell-allograft constructs into clinically applicable grafts. We designed a study to evaluate the number of MSCs in an autograft femoral head considered as the gold standard and to determine the best operating room procedure for loading in allograft with MSCs to approach the same number as in an autograft femoral head. Therefore this study explored a potential of charging whole femoral head allografts with autologous MSCs from iliac crest aspirate for hip revision procedures.
METHODS: First, the study evaluated the total number of mesenchymal stem cells (MSCs) in 1 cc of an average autograft femoral head; this number then serves as a target for loading allografts, in order to achieve the same density of MSCs. For the loading technique itself, several questions were asked and hence several options were investigated. For example, is it better to load the whole allograft or break it up into several fragments? Which way of injecting works best for the whole femoral head allograft (through cartilage or femoral neck)? How concentrated (in terms of MSCs) should the injected iliac crest marrow be? Bone marrow for injection in allografts was obtained from residual marrow from patients undergoing surgical procedures with concentrated bone marrow. With this bone marrow (with and without concentration) we tested different techniques (injection and soaking) to load stem cells in allografts of different sizes: bulk allografts, pieces or blocks (8 or 1 cm(3) blocks) and morselized fragments (from 125 to 8 mm(3)) or particules (1 mm(3)). We also evaluated the release of MSCs from fragments of autografts and allografts loaded with MSCs in cultured medium.
RESULTS: The femoral head autografts contained a lower concentration of MSCs than the iliac crests of the same patient. However, in absence of concentration, with bone marrow aspirated from the iliac crest, we were not able to load in the femoral head allograft the same number of MSCs as the number present in an autograft. The loaded volume of bone marrow (and the corresponding number of MSCs) depended on the technique (injecting, soaking) as well as on the volume and shape of the allografts. The seeding efficiency of loading MSCs in allografts increased with the concentration of MSCs in the bone marrow. With concentrated bone marrow, supercharging the allograft with MSCs (as compared with an autograft) was possible in the operating room, and the number of MSCs supercharged in allografts was predictable.
CONCLUSIONS: The loaded volume of bone marrow depended on the technique (injecting, soaking) as well as on the volume and shape of the allografts. With concentrated bone marrow, the allograft could be charged with a similar or higher number of MSCs than the number present in a femoral head autograft.

Entities:  

Mesh:

Year:  2013        PMID: 24323352     DOI: 10.1007/s00264-013-2221-x

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  19 in total

1.  Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone.

Authors:  Richard Tuli; Suraj Tuli; Sumon Nandi; Mark L Wang; Peter G Alexander; Hana Haleem-Smith; William J Hozack; Paul A Manner; Keith G Danielson; Rocky S Tuan
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

2.  Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates.

Authors:  Yusuke Sakaguchi; Ichiro Sekiya; Kazuyoshi Yagishita; Shizuko Ichinose; Kenichi Shinomiya; Takeshi Muneta
Journal:  Blood       Date:  2004-07-08       Impact factor: 22.113

3.  Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells.

Authors:  Ph Hernigou; A Poignard; F Beaujean; H Rouard
Journal:  J Bone Joint Surg Am       Date:  2005-07       Impact factor: 5.284

Review 4.  Bone allografts: What they can offer and what they cannot.

Authors:  C Delloye; O Cornu; V Druez; O Barbier
Journal:  J Bone Joint Surg Br       Date:  2007-05

5.  Large-scale extraction and characterization of CD271+ multipotential stromal cells from trabecular bone in health and osteoarthritis: implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cells.

Authors:  E Jones; A English; S M Churchman; D Kouroupis; S A Boxall; S Kinsey; P G Giannoudis; P Emery; D McGonagle
Journal:  Arthritis Rheum       Date:  2010-07

Review 6.  Stromal stem cells: marrow-derived osteogenic precursors.

Authors:  M Owen; A J Friedenstein
Journal:  Ciba Found Symp       Date:  1988

7.  Composition and mechanical properties of cancellous bone from the femoral head of patients with osteoporosis or osteoarthritis.

Authors:  B Li; R M Aspden
Journal:  J Bone Miner Res       Date:  1997-04       Impact factor: 6.741

8.  In vivo and in vitro comparison of three different allografts vitalized with human mesenchymal stromal cells.

Authors:  Laura Coquelin; Anne Fialaire-Legendre; Stephan Roux; Alexandre Poignard; Philippe Bierling; Philippe Hernigou; Nathalie Chevallier; Hélène Rouard
Journal:  Tissue Eng Part A       Date:  2012-07-02       Impact factor: 3.845

9.  Platelet lysate coating on scaffolds directly and indirectly enhances cell migration, improving bone and blood vessel formation.

Authors:  Julie Leotot; Laura Coquelin; Gwellaouen Bodivit; Philippe Bierling; Philippe Hernigou; Helene Rouard; Nathalie Chevallier
Journal:  Acta Biomater       Date:  2013-02-09       Impact factor: 8.947

Review 10.  Why are MSCs therapeutic? New data: new insight.

Authors:  A I Caplan
Journal:  J Pathol       Date:  2009-01       Impact factor: 7.996

View more
  10 in total

Review 1.  History of concentrated or expanded mesenchymal stem cells for hip osteonecrosis: is there a target number for osteonecrosis repair?

Authors:  Philippe Hernigou; Gilles Guerin; Yasuhiro Homma; Arnaud Dubory; Nathalie Chevallier; Hélène Rouard; Charles Henri Flouzat Lachaniette
Journal:  Int Orthop       Date:  2018-05-24       Impact factor: 3.075

2.  Supercharging irradiated allografts with mesenchymal stem cells improves acetabular bone grafting in revision arthroplasty.

Authors:  Philippe Hernigou; Jacques Pariat; Steffen Queinnec; Yasuhiro Homma; Charles Henri Flouzat Lachaniette; Nathalie Chevallier; Helene Rouard
Journal:  Int Orthop       Date:  2014-02-09       Impact factor: 3.075

3.  Multipotential stromal cell abundance in cellular bone allograft: comparison with fresh age-matched iliac crest bone and bone marrow aspirate.

Authors:  Thomas G Baboolal; Sally A Boxall; Yasser M El-Sherbiny; Timothy A Moseley; Richard J Cuthbert; Peter V Giannoudis; Dennis McGonagle; Elena Jones
Journal:  Regen Med       Date:  2014-03-12       Impact factor: 3.806

4.  Single-stage treatment of infected tibial non-unions and osteomyelitis with bone marrow granulocytes precursors protecting bone graft.

Authors:  Philippe Hernigou; Arnaud Dubory; Yasuhiro Homma; Charles Henri Flouzat Lachaniette; Nathalie Chevallier; Helene Rouard
Journal:  Int Orthop       Date:  2017-11-13       Impact factor: 3.075

5.  Regenerative therapy with mesenchymal stem cells at the site of malignant primary bone tumour resection: what are the risks of early or late local recurrence?

Authors:  Philippe Hernigou; Charles Henri Flouzat Lachaniette; Jerome Delambre; Nathalie Chevallier; Helene Rouard
Journal:  Int Orthop       Date:  2014-06-07       Impact factor: 3.075

6.  Allografts supercharged with bone-marrow-derived mesenchymal stem cells possess equivalent osteogenic capacity to that of autograft: a study with long-term follow-ups of human biopsies.

Authors:  Philippe Hernigou; Arnaud Dubory; François Roubineau; Yasuhiro Homma; Charles Henri Flouzat-Lachaniette; Nathalie Chevallier; Helene Rouard
Journal:  Int Orthop       Date:  2016-08-24       Impact factor: 3.075

Review 7.  Stem Cell Considerations for the Clinician.

Authors:  Karen A Hasty; Hongsik Cho
Journal:  Phys Med Rehabil Clin N Am       Date:  2016-11       Impact factor: 1.784

Review 8.  Bone marrow derived stem cells in joint and bone diseases: a concise review.

Authors:  Antonio Marmotti; Laura de Girolamo; Davide Edoardo Bonasia; Matteo Bruzzone; Silvia Mattia; Roberto Rossi; Angela Montaruli; Federico Dettoni; Filippo Castoldi; Giuseppe Peretti
Journal:  Int Orthop       Date:  2014-07-09       Impact factor: 3.075

9.  Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred and twenty five adult patients.

Authors:  Philippe Hernigou; Arnaud Dubory; Yasuhiro Homma; Isaac Guissou; Charles Henri Flouzat Lachaniette; Nathalie Chevallier; Hélène Rouard
Journal:  Int Orthop       Date:  2018-05-09       Impact factor: 3.075

Review 10.  Stem Cell Therapy for the Treatment of Hip Osteonecrosis: A 30-Year Review of Progress.

Authors:  Philippe Hernigou; Matthieu Trousselier; François Roubineau; Charlie Bouthors; Nathalie Chevallier; Helene Rouard; Charles-Henri Flouzat-Lachaniette
Journal:  Clin Orthop Surg       Date:  2016-02-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.